Did you know that 20 000 Osstell users in the world has it: ISQ has become a standard in objective implant stability measurement, helping clinicians to reduce treatement times and manage risk patients.

We asked clinicians that we met at AO 2017 in Orlando and IDS 2017 in Cologne if they do ISQ.

Yes, they do ISQ! Do you?

Jonas Ehinger, CEO Osstell and Dr. Scott Ganz at AO 2017 in Orlando, FL

Dr. Thomas Balshi at AO 2017 in Orlando, FL

Jonas Ehinger, CEO Osstell and Dr. Marcus Dagnelid at IDS 2017 in Cologne, Germany

Dr. Toni Neumeier at AO 2017 in Orlando, FL

Jonas Ehinger, CEO Osstell and Dr. Dirk Duddek at IDS 2017 in Cologne, Germany

Niclas Horal-Schultz, Director of Sales Osstell and Dr. Mauro Labanca at IDS 2017 in Cologne, Germany

Dr. Jack Krauser at AO 2017 in Orlando, FL

Jonas Ehinger, CEO Osstell and Dr. Christian Stangenberg at IDS 2017 in Cologne, Germany

Dr. Isaac D Tawil and Dr. Scott Ganz at IDS 2017 in Cologne, Germany

IDS 2017 in Cologne, Germany